TrialJournal of the National Cancer Institute2018
Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial.
Mahboobeh Safaeian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
49 papers cite it
this paperpooled ittrialcites it